Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to fall 21.55% to 34 cents per share on April 30

Q1'25

Est.

$0.35

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.10

Q2'24

Est.

$0.33

Q1'24

Missed

by $0.02

The last earnings report on February 20 showed earnings per share of 43 cents, beating the estimate of 40 cents. With 624.32K shares outstanding, the current market capitalization sits at 10.26B.

View a ticker or compare two or three

Compare

RGEN